Old Web
English
Sign In
Acemap
>
authorDetail
>
Ph van Berkel
Ph van Berkel
Pyrrolobenzodiazepine
Antibody-drug conjugate
Antibody
Combinatorial chemistry
Engineering
3
Papers
11
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Characterization of the mechanism of action, pharmacodynamics and preclinical safety of ADCT-402, a pyrrolobenzodiazepine (PBD) dimer-containing antibody-drug conjugate (ADC) targeting CD19-expressing hematological malignancies
2017
Francesca Zammarchi
Simon Corbett
Karin Havenith
Narinder Janghra
Konstantinos Kiakos
Teresa Marafioti
David G. Williams
Simon Chivers
Philip Howard
John A. Hartley
Ph van Berkel
Show All
Source
Cite
Save
Citations (0)
ADCT-502, a novel pyrrolobenzodiazepine (PBD)-based antibody-drug conjugate (ADC) targeting low HER2-expressing solid cancers
2016
European Journal of Cancer
Francesca Zammarchi
Simon Chivers
David G. Williams
Lauren Adams
Maria Mellinas-Gomez
Peter Tyrer
Simon Corbett
Francois DHooge
Sandamali Dissanayake
S Sims
Karin Havenith
Philip Howard
John A. Hartley
Ph van Berkel
Show All
Source
Cite
Save
Citations (11)
Pyrrolobenzodiazepine (PBD) dimers - potent next generation warheads in antibody drug conjugates (ADCs) targeted at both solid and haematological tumors.
2013
John A. Hartley
Luke Masterson
Stephen J. Gregson
Thais Cailleau
Ebele Ezeadi
J. N. Levy
Gary C. Kemp
A Tiberghlen
E Dunny
Francois DHooge
Lauren Adams
Deborah Williams
Ph van Berkel
Philip Howard
Show All
Source
Cite
Save
Citations (0)
1